Consolidated statements of income and comprehensive income/loss (-)
(unaudited)
|
Third quarter of |
Nine months ended 30 September |
||||
---|---|---|---|---|---|---|
(thousands of €, except per share data) |
2021 |
2020(*) |
2021 |
2020(*) |
||
Product net sales |
5,691 |
- |
6,147 |
- |
||
Collaboration revenues |
58,503 |
127,519 |
311,711 |
321,923 |
||
Total revenues |
64,194 |
127,519 |
317,858 |
321,923 |
||
|
|
|
|
|
||
Cost of sales |
(529) |
- |
(660) |
- |
||
Research and development expenditure |
(109,196) |
(129,298) |
(378,022) |
(392,199) |
||
Sales and marketing expenses |
(17,655) |
(17,187) |
(46,616) |
(44,109) |
||
General and administrative expenses |
(27,793) |
(26,529) |
(104,651) |
(88,303) |
||
Other operating income |
12,781 |
12,201 |
36,345 |
35,003 |
||
|
|
|
|
|
||
Operating loss |
(78,199) |
(33,294) |
(175,747) |
(167,685) |
||
|
|
|
|
|
||
Fair value re-measurement of warrants |
197 |
13,033 |
3,025 |
(8,085) |
||
Other financial income |
23,694 |
(295) |
60,267 |
13,919 |
||
Other financial expenses |
(10,148) |
(61,950) |
(29,633) |
(89,190) |
||
|
|
|
|
|
||
Loss before tax |
(64,456) |
(82,505) |
(142,088) |
(251,040) |
||
|
|
|
|
|
||
Income taxes |
(157) |
(14) |
316 |
(723) |
||
|
|
|
|
|
||
Net loss from continuing operations |
(64,613) |
(82,519) |
(141,772) |
(251,763) |
||
|
|
|
|
|
||
Net profit from discontinued operations, net of tax |
- |
614 |
22,191 |
4,215 |
||
|
|
|
|
|
||
Net loss |
(64,613) |
(81,905) |
(119,581) |
(247,548) |
||
Net loss attributable to: |
|
|
|
|
||
Owners of the parent |
(64,613) |
(81,905) |
(119,581) |
(247,548) |
||
Basic and diluted loss per share |
(0.99) |
(1.25) |
(1.83) |
(3.81) |
||
Basic and diluted loss per share from continuing operations |
(0.99) |
(1.26) |
(2.16) |
(3.87) |
||
|
The accompanying notes form an integral part of these condensed consolidated financial statements.
|
Third quarter of |
Nine months ended 30 September |
||||
---|---|---|---|---|---|---|
(thousands of €) |
2021 |
2020(*) |
2021 |
2020(*) |
||
Net loss |
(64,613) |
(81,905) |
(119,581) |
(247,548) |
||
Items that may be reclassified subsequently to profit or loss: |
|
|
|
|
||
Translation differences, arisen from translating foreign activities |
(32) |
(688) |
171 |
(350) |
||
Realization of translation differences upon sale of foreign operations |
- |
(1,023) |
731 |
(1,023) |
||
Other comprehensive income/loss (-), net of income tax |
(32) |
(1,711) |
902 |
(1,373) |
||
|
|
|
|
|
||
Total comprehensive loss attributable to: |
|
|
|
|
||
Owners of the parent |
(64,645) |
(83,616) |
(118,679) |
(248,920) |
||
|
|
|
|
|
||
Total comprehensive loss attributable to owners of the parent arises from: |
|
|
|
|
||
Continuing operations |
(64,645) |
(84,244) |
(141,601) |
(252,906) |
||
Discontinued operations |
- |
628 |
22,922 |
3,985 |
||
Total comprehensive loss |
(64,645) |
(83,616) |
(118,679) |
(248,920) |
||
|
The accompanying notes form an integral part of these condensed consolidated financial statements.